急性および慢性疼痛の治療のための非オピオイド疼痛管理製品の買収、開発、商品化に焦点を当てた革新的な収益創出会社であるScilex Holding Company(NASDAQ:SCLX、「Scilex...
ログインすると全部閲覧できます。
ログイン
Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company"))))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, provides notice to all record holders and beneficial owners of restricted shares of Scilex common stock that were part of the previously announced dividend of Scilex common stock then-held by Sorrento Therapeutics, Inc. (OTC:SRNEQ, "Sorrento"))))) to Sorrento equity holders of record as of January 9, 2023.
NOTICE TO ALL RECORD HOLDERS AND BENEFICIAL OWNERS OF RESTRICTED SHARES OF SCILEX HOLDING COMPANY
On December 30, 2022, Sorrento Therapeutics, Inc. ("Sorrento") announced...
急性および慢性疼痛の治療のための非オピオイド疼痛管理製品の買収、開発、商品化に焦点を当てた革新的な収益創出会社であるScilex Holding Company(NASDAQ:SCLX、「Scilex...
ブラウザの共有ボタンを使って、このページを友人と共有することができます。